Xila 50ml Interchemie

DESCRIPTION

Xyla is a drug in the form of a solution for injection, intended for use by animals as a sedative, analgesic, anesthetic and muscle relaxant. The drug in appearance is a clear, colorless injection solution.

COMPOSITION

Xyla contains xylazine hydrochloride as an active ingredient - 20 mg / ml, as well as auxiliary components: sodium metabisulfate - 1 mg, citric acid - 1 O mg, benzyl alcohol - 0.01 ml, sodium hydroxide to pH = 5.O, water for injection - up to 1 ml.

PHARMACOLOGICAL PROPERTIES

Xylazine hydrochloride, which is part of the drug, is an antagonist of central ОІ 2 -adrenergic receptors, has a sedative, muscle relaxation and analgesic effect, stimulates both central and peripheral alpha receptors. When administered parenterally, it causes a rapid onset of dissociated anesthesia.

After intramuscular or subcutaneous administration, the onset of action of the drug occurs after 5 to 20 minutes, with intravenous administration - after 1 to 5 minutes. The duration of the sedative effect varies in cattle from 30 minutes to 5 hours, in horses - from 30 minutes to 1 hour, in small domestic animals - from 1 to 2 hours. The analgesic effect lasts up to 45 minutes in cattle, in small animals - from 15 to 30 minutes, in horses, the duration varies from 5 to 20 minutes, depending on the dosage and individual sensitivity of the organism. The muscle relaxation effect in animals occurs in 20 - 50 minutes. Xylazine hydrochloride enhances the effect of tranquilizers, cataleptic and anesthetics, as a result of which it should be used with caution with drugs of these groups.

According to the degree of impact on the body, Xila belongs to moderately hazardous substances (hazard class 3 in accordance with GOST 12.1.007-76), in recommended doses it does not have a local irritating and sensitizing effect.

INDICATIONS

Xyla is used in cattle, sheep, horses, dogs and cats as a sedative, analgesic and muscle relaxation agent: to prevent the aggressiveness and fearfulness of animals during various interventions and treatments (surgery, castration, blood collection, X-ray examination, wound treatment, suturing on wounds, removal of stitches, removal of a foreign body, catheterization, treatment of eyes and ears, general and local anesthesia, etc.), as well as transportation.

DOSAGE AND APPLICATION

Ksila is administered intramuscularly or intravenously (slowly, over 1 - 2 minutes).

When prescribing Xyla to animals, a preliminary 12-24 hour fasting diet is recommended. The animal should not be disturbed for 5-1 O minutes after injection. There is no stage of excitement and violence when using the drug.

For cattle, the drug is administered intramuscularly in the following doses: for calming the animal and small interventions - 0.25-0.5 ml / 100 kg of live weight. Can be administered to animals in a standing position. In exceptional cases, during long-term operations - 1.5 ml / 100 kg of live weight. The animals are fixed in a supine position.

Sheep is injected intramuscularly at a dose of O, 15 ml / 10 kg of live weight.

For horses, the drug is administered at a dose of 3-5 ml / 100 kg of live weight intravenously or 1 O ml / 100 kg of live weight intramuscularly.

During manipulations that are not accompanied by painful manifestations, dogs are injected intramuscularly with atropine sulfate at a dose of 0.05 mg / kg of animal weight: O, 1 ml / kg of animal weight - during transportation, clinical research, catheterization, blood collection, changing dressings; Oh, 15 ml / kg of animal weight - to achieve a pronounced relaxation of the muscles during treatment procedures that require a recumbent position of the animal (opening an abscess, surgical treatment of wounds, suturing, etc.); 0.2 ml / kg of animal weight - for complete immobilization of the animal for 20-50 minutes and a significant weakening of pain sensitivity during prolonged operations.

Ksilu is administered to animals once. If the desired degree of sedation is not achieved, additional injections are not recommended to achieve the desired effect.

FEATURES

Xylanit is prohibited for females in the last third of pregnancy, due to the oxytocin-like effect on the uterus, except for cases of obstetrics, to animals with mechanical damage to the gastrointestinal tract (blockage of the esophagus, volvulus, hernia), with a history of cardiac muscle conduction disorder. For animals with lung disease, the drug should be used with caution.

Slaughter of animals for meat is allowed no earlier than 5 days after the last application of Xylanit. The meat of animals that were forcedly killed before the expiration of the specified period can be used as feed for fur animals. Milk of dairy animals within 4 days after the application of Xylanit is prohibited to use for food purposes, it can be used for feeding animals after heat treatment.

SHELF LIFE AND STORAGE

Xylanit should be stored out of the reach of children. Store Xylanit in closed manufacturer's packaging, separately from food and feed, in a dry place protected from direct sunlight at a temperature of 2 В° C to 25 В° C. The shelf life of the medicinal product, subject to storage conditions in a sealed package, is 3 years from the date of manufacture. After opening, the bottle is stored for no more than 28 days. Xylanit after the expiration date should not be applied.

PACKAGING

The drug is produced sterile packaged in 50 ml each in hermetically sealed glass vials, sealed with rubber stoppers and rolled aluminum caps.

Specifications

Bonus points

0

KolVUP

24

Manufacturer

Interchemie

Temperature regime

from +2 to +25

Teaser

to prevent aggressiveness and fearfulness of animals during various interventions and treatments